SecondWave Systems

SecondWave Systems is a private, preclinical-stage biotech firm pioneering a wearable ultrasound platform for noninvasive neuromodulation and treatment of chronic diseases. Founded in 2016 and based in Minnetonka, Minnesota, the company leverages proprietary sensing and imaging to enable adaptive, personalized therapy for conditions like inflammation and pain. With a leadership team experienced in ultrasound technology and medical device commercialization, SecondWave aims to disrupt treatment paradigms reliant on drugs and invasive procedures, though it faces significant development, regulatory, and competitive hurdles typical of novel medical devices.

Wearable, noninvasive ultrasound stimulation platform with integrated sensing and imaging for adaptive neuromodulation and cellular modulation.

SecondWave competes in the broader neuromodulation and bioelectronic medicine market against established players like Medtronic (spinal cord, deep brain stimulation) and Abbott, as well as startups using electrical (e.g., electroceuticals) and magnetic stimulation. Its focus on wearable, noninvasive ultrasound is a differentiating but not yet validated approach.